Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.75%
#4 aPriori aPriori +131.95%
#5 Bedrock Bedrock +76.08%
#6 Cysic Cysic +50.91%
#7 Prom Prom +45.70%
#8 Playnance Playnance +35.00%
#9 Bitway Bitway +27.78%
#10 COTI COTI +27.04%
Coin of the day
Wrapped One Wrapped One
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals, Inc.

SNNAQ
Rangering i aksjer #42234
Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm... Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm dedicated to discovering and advancing pharmaceutical treatments across diverse therapeutic fields. Its primary focus involved crafting therapies within immunology and inflammation, specifically targeting particular tissue pathways, notably in the skin. Among its pipeline, SNA-120 stood out as a pioneering, first-in-class inhibitor of tropomyosin receptor kinase A, undergoing Phase IIb clinical evaluation for addressing psoriasis and its associated itching. Another key candidate, SNA-125, a topical dual Janus kinase 3 inhibitor, progressed through Phase I/II clinical studies for conditions like atopic dermatitis, psoriasis, and pruritus. Furthermore, Sienna was advancing SNA-001, a topical suspension incorporating silver particles, into pivotal clinical trials not only for acne treatment but also for diminishing light-colored hair, encompassing shades such as white, gray, blonde, light brown, and light red. Established in 2010 and based in Westlake Village, California, the company originally operated as Sienna Labs, Inc. before rebranding as Sienna Biopharmaceuticals, Inc. in February 2016. However, the firm faced significant financial challenges, initiating Chapter 11 bankruptcy proceedings on September 16, 2019, which subsequently converted to Chapter 7 liquidation on December 18, 2019.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$3.09K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Sienna Biopharmaceuticals, Inc. (SNNAQ)

Kategori

Healthcare
Pris SNNAQ pris med markedsverdi på B
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.0001
Markedsverdi av Sienna Biopharmaceuticals, Inc.(SNNAQ)
Markedsverdi: $3.09K
Per August 2026 har Sienna Biopharmaceuticals, Inc. en markedsverdi på $3.09K. Dette gjør Sienna Biopharmaceuticals, Inc. til det 42234th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Sienna Biopharmaceuticals, Inc. fra 2017 til 2026
SNNAQ sammenlignet med topp 5 mest populære stocks
Pris på SNNAQ Eiendel B Markedsverdi for B Resultater
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$174,162 $3.09K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +174,162,389,417.96%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$143,106 $3.09K
Apple Inc. Apple Inc.
AAPL
$4.423T +143,105,506,329.57%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$134,596 $3.09K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +134,596,227,628.31%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$118,516 $3.09K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +118,515,717,693.59%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$93,537.00 $3.09K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +93,537,003,956.94%